What This Immunome Sale Signals Ahead of FDA Milestone
When a biotech firm nears a major FDA decision, every insider transaction can feel like a tell. This article dives in...
Active funds frequently lag behind due to fees and manager risk, while index funds provide broad exposure with lower costs and smoother performance.
22,822 articlesWhen a biotech firm nears a major FDA decision, every insider transaction can feel like a tell. This article dives in...
Garmin stock soared this week after the GPS giant posted a solid Q4 and guided higher for 2026. This article breaks d...
Stocks with elevated short interest are driving today’s moves as investors weigh earnings signals and macro risks. Th...
A new wave of investors is changing how rental markets work. Out-of-town buyers are driving rental demand in many top...
Learn how xometry (xmtr) 2026 earnings shape the investment case. We break down the numbers, strategy, and risks, wit...
Latin America's fintech leaders have faced a choppy earnings season, but patient investors see potential. This guide ...
A fast-growing Brazilian fintech is reshaping personal finance in Latin America. Here are three concrete reasons this...
Bitcoin faces a historic moment as issuance nears its 21 million cap. This piece explains what happens when bitcoin r...
The june jobs report came in well below forecasts, adding 57,000 payrolls and prompting a shift in Fed expectations a...
Meta Platforms stock surged this week as investors cheered hints of in-house AI chips and bigger cloud capacity. We b...
Digital health is redefining care delivery and costs. This guide shows how to find a high-growth healthcare stock ear...
This deep dive breaks down AKA Brands' 2025 Q4 results. Learn what the numbers mean for the business, where growth ca...